In postpartum #preeclampsia, furosemide vs placebo was associated with lower mean systolic BP on postpartum days 1 & 5, lower diastolic BP on days 1, 2 & 5, and shorter time to BP control.
Read more: https://t.co/aqZM270WHG
#postpartumhypertension#AJOGMFM
Maternal diabetes during pregnancy was associated with increased risk of overall #CardiovascularDisease and specific CVD subtypes in offspring, with congenital heart disease, preterm birth, and large for gestational age mediating part of the association. https://t.co/Vd2qwDWbrM
Coronary plaque in younger women may carry a far greater prognostic signal than equivalent plaque in men.
In our editorial in the Am Journal of Preventive Cardiology (https://t.co/s5vcvNHkSp), we discuss why sex-specific interpretation of CCTA findings is essential—and why even “mild” plaque in women should prompt aggressive prevention efforts.
#CardioTwitter #CCTA #WomensHeartHealth
The American Heart Association mourns the passing of the legendary cardiologist Eugene Braunwald, M.D., widely recognized as one of the most influential figures in the history of cardiovascular medicine. Over seven decades, his work reshaped the understanding and treatment of heart disease, leading many to call him the father of modern cardiology.
Braunwald was a lifelong contributor to the American Heart Association, helping advance its research and scientific mission, and was honored with some of the Association’s highest honors for his lasting influence on cardiovascular care and research. His influence extended well beyond his own discoveries, as generations of Association‑supported investigators, clinicians and academic leaders were trained by Braunwald or guided by the clinical trial standards and mentorship models he helped establish.
https://t.co/ieZuHYMyOP
Cardiovascular disease remains the leading cause of death in women, yet traditional models miss key risks like hormonal factors, pregnancy-related conditions, and therapy differences.
It’s time for precision, personalized care.
https://t.co/Ktf3mxbpGV
Grateful to my mentor @AllanLKleinMD1 for his leadership in pericardial disease and for the opportunity to learn from cases like this in a truly world class environment. @jibran_ikram
Clinical course, imaging, and hemodynamics define the transition to fixed constriction. IL-1 blockade treats inflammation, not fibrosis, but may be continued perioperatively to prevent rebound inflammation. @JACCJournals
https://t.co/CHm8qdDis2
In a US cohort, higher systolic #BloodPressure genetic risk was associated with new-onset #Hypertension after pregnancy, but elevated postpartum body mass index and hypertensive disorders of pregnancy were stronger risk factors.
https://t.co/0P5evC1gbg
Welcome to our APRIL 1 SPECIAL CARDIO OBSTETRICS issue of #JACCCaseReports@JACCJournals.
https://t.co/HEW4oV37b4
Full PDF here:
https://t.co/d2J1v7P0yH
Thank you @MinnowWalsh for leading this special issue!
@hmkyale@Justine_Turco
JACC: Case Reports and Cardio-Obstetric Essentials
https://t.co/Noe2j9AuMK
Imaging:
Navigating the Aortopathy Dilemma in Pregnancy: Case Series Insights From a Cardiac Surgical Center
https://t.co/ejJTM77Dcn
Heart Failure and Cardiomyopathies:
Temporary Left Ventricular Assist Device for Peripartum Cardiogenic Shock as a Bridge to Cesarean Delivery
https://t.co/kP8djeIoKK
Group 5 Pulmonary Hypertension Resulting From Thyrotoxicosis During Pregnancy
https://t.co/XjKCBlE0Mw
Chemotherapy-Induced Cardiomyopathy in Pregnancy: A Multidisciplinary Approach
https://t.co/3Ps5Qvijm6
Calcific Constrictive Tuberculous Pericarditis in Pregnancy: A Shared Decision-Making Approach
https://t.co/s5Y5W9doah
Rhythm Disorders and Electrophysiology:
Asymptomatic Complete Heart Block in Pregnancy
https://t.co/MvlX7nwiWs
Fascicular Ventricular Tachycardia in Pregnancy
https://t.co/HQDPcxaxiz
Vascular Medicine:
Fibrosing Mediastinitis in Pregnancy: A Rare Case with Antepartum Hemoptysis and Airway Obstruction
https://t.co/jHaUG2Aows
Pregnancy-Associated Spontaneous Coronary Artery Dissection in a 32-Year-Old Woman With Postpartum Hemorrhage
https://t.co/ZV05sDCHpD
Cardiometabolic:
Gestational Hypertriglyceridemia Management and the Utility of Multidisciplinary Care
https://t.co/1rv2CuJl8O
Congenital Heart Disease:
Patent Foramen Ovale–Induced Hypoxemia Unmasked During Pregnancy
https://t.co/e7xBj526Ko
Imaging:
A Cardio-Obstetric Breakthrough Beyond Routine Pregnancy Care: Unmasking Hodgkin’s Lymphoma
https://t.co/ZCKkVSpm70
Ischemic Heart Disease:
Silent Myocardial Infarction in Pregnancy Uncovered During Routine Antenatal Echocardiographic Screening
https://t.co/idgdo1OJ9k
Outcomes and Quality:
Cardiac Tamponade Revealing a New Diagnosis of Malignancy: When Intervention Is the Answer
https://t.co/HMvBqYUJey
Valvular Heart Disease:
Managing Pregnancy in the Presence of Rheumatic Heart Disease and Antiphospholipid Syndrome
https://t.co/YLxIVdNskz
Percutaneous Mechanical Aspiration Thrombectomy-Assisted Management of Right-Sided Infective Endocarditis During Pregnancy
https://t.co/A3hyiGcIxt
Health Promotion and Preventive Cardiology:
Creating a Cardio-Obstetrics Elective as a Fellow In Training
https://t.co/FuI6uGTzBv
Outcomes and Quality:
Early Outcomes of an Extended Postpartum Hypertension Program: Care Beyond Delivery
https://t.co/RF6QgU6A9O
Valvular Heart Disease:
Transcaval SESAME, LAMPOON, and Valve-in-MAC: First Experience With SESAME Outside the United States
https://t.co/UBxALVAkOr
The Next Era of Transcatheter Electrosurgery for Structural Heart Interventions
https://t.co/KPrXyMGz7C
A Very Late Mitral Valve Hypoattenuated Leaflet Thickening With Significant Warfarin Response
https://t.co/03lTctlVRP
Obstructive Hypoattenuated Leaflet Thickening in a Complex Valve-in-Valve TAVR Successfully Treated With Thrombolysis
https://t.co/zMKEn4X527
Thrombolysis for Obstructive HALT in Complex Valve-in-Valve TAVR
https://t.co/ll5O3yVmT9
Severe Aortic and Mitral Regurgitation After Blunt Chest Trauma
https://t.co/li54g1fifE
When Trauma Obscures the Heart: Diagnostic Blind Spots After Blunt Chest Injury
https://t.co/Z8tnhGLt4w
Coronary, Peripheral and Structural Interventions:
Transapical Edge-to-Edge Repair for Systolic Anterior Motion in Obstructive Hypertrophic Cardiomyopathy
https://t.co/qNi0gveZwf
Management of Coronary Artery Perforations: A Stepwise, Case-Based Review From a High-Volume Center
https://t.co/PzYv2Pn7QS
Post-Myocardial Infarction Ventricular Septal Defect Percutaneous Closure
https://t.co/YMDfVMfAa9
Atypical Presentation of Mycotic Coronary Artery Aneurysm
https://t.co/G00RnehzRl
Laser-Assisted OPN Technique for Recalcitrant Multilayer In-Stent Restenosis: A Systematic Approach
https://t.co/s21ddvvbWH
Percutaneous Rescue With Sequential Second-Device Usage for Left Atrial Appendage Perforation During Amulet Implantation
https://t.co/HqWFNGDnhv
Imaging:
High-Output Heart Failure Associated With Arteriovenous Fistula
https://t.co/dfh3hbN2Dh
Heart Failure and Cardiomyopathies:
Hemodialysis Access–Related High-Output Heart Failure: From Mechanisms to Multidisciplinary Management
https://t.co/T7USgOPA8s
Imaging:
“Flying Saucer”–Like Morphology in Infective Endocarditis Arising on a Stenotic Mitral Valve
https://t.co/NDAI43bPUt
Purulent Pericarditis Complicated With Cardiac Tamponade, Multiorgan Failure, and Constrictive Pericarditis
https://t.co/zMCORH8Rcw
Primary Cardiac Lymphoma Presenting With Chest Pain
https://t.co/t7otEAziRJ
Rhythm Disorders and Electrophysiology:
Combined Lead Extraction and Leadless VDD Pacemaker Implantation in d-TGA Patient After Senning Procedure
https://t.co/wrwZpJUrrq
Leadless Pacing and the Emerging Era of Combined Procedures in Adult Congenital Heart Disease
https://t.co/S3z7hVn1Do
Propafenone Overdose Presenting With Brugada Phenocopy, QRS Widening, and Ventricular Fibrillation
https://t.co/6BFgsBsEWO
15-Year ECG Evolution of Interatrial Block and Effects of Atrial Septal Pacing
https://t.co/xVP4HPoOa3
@aronisMD@JACabreraCardio@MiChen__@aabha_divya@sarano_maurice@Miho_Fukui_@ErikaHuttce@Nishaki1@ChrissyMD2000@ACHDocTMoe@M_Pompeu_Sa_MD@jsaef1@JTSaxon@AndreaScotti21@Kentso987@TagliariPaula@m_taramasso@SyedZaidMD
The #PCSK9 inhibitor evolocumab ↘️ the risk of a first major CV event in patients w/ diabetes without known significant atherosclerosis, according to a prespecified subgroup analysis of the VESALIUS-CV trial, presented during a LBCT session at #ACC26. 🔗 https://t.co/PeVZAxY1ik
🆕 #ACC26 Late-Breaking Trial 👇
Ez-PAVE: Lowering LDL-C to <55 mg/dL in patients with #ASCVD reduced the rate of major cardiovascular events by one-third.
Want the full results? Keep reading ➡️ https://t.co/EwRI1xLOle #cvPrev
GoFreshRx: Home-Delivered DASH Groceries Improve BP and LDL-C in Black Adults With Hypertension
Find out more and follow for ACC's full meeting coverage of the latest science from #ACC26 👉 https://t.co/GFteKwKkhz #cvPrev#CardioX
PCSK9 inhibitors transformed secondary prevention—
but what about primary prevention?
#VESALIUS-CV evaluates evolocumab in patients without established ASCVD.
Could this expand who we treat—and when?
➡️ Key results: evolocumab⤵️ CV events in this high risk primary prevention study!
56% 💃🏻
92% White
#ACC26 #Lipids #CvPrev @JAMACardio
📎 https://t.co/CP1BMKI45X
From @JAMA_current: Among adults with high-risk #diabetes and elevated LDL cholesterol, evolocumab combined with statins reduced rates of major cardiovascular events compared to statin alone.
#ACC26@ACCinTouch
https://t.co/lNgzYJHqP7
Now in @ehj_ed#EHJ simutaneous with #ACC26, our analysis of Lp(a) and VTE risk led by ⭐️🇧🇪 @daniel_ezt
Take-🏠: Elevated Lp(a) is associated w/ ⬆️ VTE 🩸 in high-estrogen states (premenopausal 👭, + postmenopausal 👭 using hormone therapy)
Paper here: https://t.co/uVF3Ebf33Z